Latigo Biotherapeutics (LTGO) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 5 33 sessions, August 7, 2026 to September 23, 2026
- Largest daily move
- -9.1% close of August 31, 2026
Company Description
Latigo Biotherapeutics (NASDAQ: LTGO) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.3B.
LTGO has declined 10.7% over the past month. The last closing price was $19.97.
This page collects what Stock Titan holds for LTGO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latigo Biotherapeutics (LTGO) closed at $19.97 on September 23, 2026. Over the past month, the price has lost 10.7%.
LTGO Metrics & Rankings
Price returns through September 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Latigo Biotherapeutics has 2 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include earnings, IPO, offering. View all LTGO news →
SEC Filings
Latigo Biotherapeutics has filed 10 recent SEC filings, including 4 Form 4, 3 Form SCHEDULE 13G, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on September 3, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LTGO SEC filings →
Insider Radar
Insider buying activity at Latigo Biotherapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Phase 3 topline data
Latigo Biotherapeutics has 1 upcoming scheduled event. The next event, "Phase 3 topline data", is scheduled for July 1, 2027 (in 280 days). Investors can track these dates to stay informed about potential catalysts that may affect the LTGO stock price.
Short Interest History
Short interest in Latigo Biotherapeutics (LTGO) currently stands at 308.6 thousand shares, up 129.5% from the previous reporting period, representing 0.6% of the float. Since August 2026, short interest has increased by 129.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Latigo Biotherapeutics (LTGO) currently stands at 1.7 days, up 72% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 72% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.7 days.
LTGO Company Profile & Sector Positioning
Latigo Biotherapeutics (LTGO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.